Skip to main content

Federal Budget, Appropriations, & Taxes

June 25, 2021
WASHINGTON, DC – Congressman Sanford D. Bishop, Jr. (GA-02) voted to pass the Fiscal Year (FY) 2022 Financial Services and General Government (FSGG) funding bill after its markup in subcommittee. It includes $29.1 billion in discretionary funding, an increase of $4.8 billion over 2021. The bill now moves to the full Appropriations Committee for consideration.
"Our small businesses and taxpayers are weathering the storm of the COVID-19 pandemic.
April 9, 2021

COLUMBUS, GA – Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement after the White House released the FY 2022 discretionary funding budget:

March 9, 2021

WASHINGTON, DC – Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies released the following statement after the House of Representatives passed the Protecting the Right to Organize (PRO) Act, H.R. 842:

February 24, 2021

WASHINGTON, DC – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement after the Rural Community Assistance Partnership (RCAP), Inc. and its national network of six regional partners honored him with the 2021 Congressional Champion Award for his outstanding service, dedication, and tireless advocacy on behalf of rural communities and small towns across the nation:

December 21, 2020

COLUMBUS, GA – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement regarding the passage of H.R. 133, the emergency COVID-19 relief and the FY21 funding bill by the full U.S House of Representatives:

December 19, 2020

WASHINGTON, DC – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement after receiving a briefing from FDA Commissioner Hahn and the Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks, on the details of FDA‘s efforts so far to review and authorize vaccines to prevent COVID-19:

October 16, 2020

COLUMBUS, GA – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, visited Sunnyland Farms in Albany to meet with members of the National Pecan Shellers, Georgia Pecan Growers Association, Georgia Pecan Commission, and the University of Georgia's Associate Deans of Research and Engineering.

October 7, 2020

COLUMBUS, GA – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement regarding the recent Food and Agriculture Service Learning Program Grant awarded to Fort Valley State University by the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA):

October 1, 2020

WASHINGTON, DC – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement regarding the passage of the updated Heroes Act by the full U.S. House of Representatives:

September 22, 2020

WASHINGTON, DC – Today, Congressman Sanford D. Bishop, Jr. (GA-02), Chairman of the U.S. House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, released the following statement regarding the passage of the Continuing Resolution by the full U.S. House of Representatives: